Side effects of oncologic therapies in the Pedi-Atric central Nervous System: Update on Neuroimaging Findings

Radiographics

Volumn 31, Issue 4, 2011, Pages 1123-1139

  Vázquez, Elida ^a   Delgado, Ignacio ^a   Sánchez Montañez, Angel ^a   Barber, Ignasi ^a   Sánchez Toledo, José ^b   Enríquez, Goya ^a  

^a Departments of Pediatric Radiology and Pediatric Oncohematology   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ARTICLE; BRAIN TUMOR; CHILD; DRUG TOXICITY; HUMAN; MALE; METHODOLOGY; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; RADIATION INJURY; RADIOTHERAPY;

ADOLESCENT; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DRUG TOXICITY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROSURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS; RADIATION INJURIES; RADIOTHERAPY;

EID: 79960534511     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.314105180     Document Type: Article

References (55)

1. Yeh JM, Nekhlyudov L, Goldie SJ, Mertens AC, Diller L. A model-based estimate of cumulative excess mortality in survivors of childhood cancer. Ann Intern Med 2010;152(7):409-417, W131-W138.
2. Parisi MT, Fahmy JL, Kaminsky CK, Malogolowkin MH. Complications of cancer therapy in children: a radiologist's guide. RadioGraphics 1999;19(2): 283-297.
3. Ullrich NJ. Inherited disorders as a risk factor and predictor of neurodevelopmental outcome in pediatric cancer. Dev Disabil Res Rev 2008;14(3): 229-237.
4. Laningham FH, Kun LE, Reddick WE, Ogg RJ, Morris EB, Pui CH. Childhood central nervous system leukemia: historical perspectives, current therapy, and acute neurological sequelae. Neuroradiology 2007;49(11):873-888.
5. Neglia JP, Robison LL, Stovall M, et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2006;98(21):1528-1537.
6. Kalifa C, Grill J. The therapy of infantile malignant brain tumors: current status? J Neurooncol 2005;75 (3):279-285.
7. Meadows AT, Friedman DL, Neglia JP, et al. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol 2009;27(14):2356-2362.
8. Panigrahy A, Blüml S. Neuroimaging of pediatric brain tumors: from basic to advanced magnetic resonance imaging (MRI). J Child Neurol 2009;24 (11):1343-1365.
9. Pollack IF. Diagnosis and treatment of childhood brain tumors: current perspectives. J Child Neurol 2009;24(11):1464-1465.
10. Kaste SC, Rodriguez-Galindo C, Furman WL, Langston J, Thompson SJ. Imaging aspects of neurologic emergencies in children treated for non- CNS malignancies. Pediatr Radiol 2000;30(8): 558-565.
11. Turner CD, Rey-Casserly C, Liptak CC, Chordas C. Late effects of therapy for pediatric brain tumor survivors. J Child Neurol 2009;24(11):1455-1463.
12. Broniscer A, Ke W, Fuller CE, Wu J, Gajjar A, Kun LE. Second neoplasms in pediatric patients with primary central nervous system tumors: the St. Jude Children's Research Hospital experience. Cancer 2004;100(10):2246-2252.
13. Ullrich NJ. Neurologic sequelae of brain tumors in children. J Child Neurol 2009;24(11):1446-1454.
14. Dubey A, Sung WS, Shaya M, et al. Complications of posterior cranial fossa surgery: an institutional experience of 500 patients. Surg Neurol 2009;72(4): 369-375.
15. Rekate HL, Grubb RL, Aram DM, Hahn JF, Ratcheson RA. Muteness of cerebellar origin. Arch Neurol 1985;42(7):697-698.
16. Doxey D, Bruce D, Sklar F, Swift D, Shapiro K. Posterior fossa syndrome: identifiable risk factors and irreversible complications. Pediatr Neurosurg 1999;31(3):131-136.
17. McMillan HJ, Keene DL, Matzinger MA, Vassilyadi M, Nzau M, Ventureyra ECG. Brainstem compression: a predictor of postoperative cerebellar mutism. Childs Nerv Syst 2009;25(6):677-681.
18. Steinbok P, Cochrane DD, Perrin R, Price A. Mutism after posterior fossa tumour resection in children: incomplete recovery on long-term follow-up. Pediatr Neurosurg 2003;39(4):179-183.
19. Rønning C, Sundet K, Due-Tønnessen B, Lundar T, Helseth E. Persistent cognitive dysfunction secondary to cerebellar injury in patients treated for posterior fossa tumors in childhood. Pediatr Neurosurg 2005;41(1):15-21.
20. Puget S, Boddaert N, Viguier D, et al. Injuries to inferior vermis and dentate nuclei predict poor neurological and neuropsychological outcome in children with malignant posterior fossa tumors. Cancer 2009;115(6):1338-1347.
21. El-Bahy K. Telovelar approach to the fourth ventricle: operative findings and results in 16 cases. Acta Neurochir (Wien) 2005;147(2):137-142.
22. Bhatia R, Tahir M, Chandler CL. The management of hydrocephalus in children with posterior fossa tumours: the role of pre-resectional endoscopic third ventriculostomy. Pediatr Neurosurg 2009;45(3): 186-191.
23. Yamini B, Refai D, Rubin CM, Frim DM. Initial endoscopic management of pineal region tumors and associated hydrocephalus: clinical series and literature review. J Neurosurg 2004;100(5 suppl pediatrics):437-441.
24. Won SC, Kwon SY, Han JW, Choi SY, Lyu CJ. Posterior reversible encephalopathy syndrome in childhood with hematologic/oncologic diseases. J Pediatr Hematol Oncol 2009;31(7):505-508.
25. Lucchini G, Grioni D, Colombini A, et al. Encephalopathy syndrome in children with hemato-oncological disorders is not always posterior and reversible. Pediatr Blood Cancer 2008;51(5):629-633.
26. Patel AJ, Fox BD, Fulkerson DH, et al. Posterior reversible encephalopathy syndrome during posterior fossa tumor resection in a child. J Neurosurg Pediatr 2010;6(4):377-380.
27. McKinney AM, Short J, Truwit CL, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 2007;189(4):904-912.
28. Yaǧmurlu B, Akyürek S, Fitoz S, Demirkazik A. MRI of non-neoplastic cranial complications of malignant disorders. Diagn Interv Radiol 2008;14(2): 61-68.
29. Fisher MJ, Khademian ZP, Simon EM, Zimmerman RA, Bilaniuk LT. Diffusion-weighted MR imaging of early methotrexate-related neurotoxicity in children. AJNR Am J Neuroradiol 2005;26(7): 1686-1689.
30. Rolf N, Boehm H, Kaindl AM, Lauterbach I, Suttorp M. Acute ascending motoric paraplegia following intrathecal chemotherapy for treatment of acute lymphoblastic leukemia in children: case reports and review of the literature. Klin Padiatr 2006;218(6): 350-354.
31. Kieslich M, Porto L, Lanfermann H, Jacobi G, Schwabe D, Böhles H. Cerebrovascular complications of L-asparaginase in the therapy of acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2003; 25(6):484-487.
32. Moharir MD, Shroff M, Stephens D, et al. Anticoagulants in pediatric cerebral sinovenous thrombosis: a safety and outcome study. Ann Neurol 2010; 67(5):590-599.
33. Sébire G, Tabarki B, Saunders DE, et al. Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain 2005; 128(pt 3):477-489.
34. Vázquez E, Lucaya J, Castellote A, et al. Neuroimaging in pediatric leukemia and lymphoma: differential diagnosis. RadioGraphics 2002;22(6): 1411-1428.
35. Gaviani P, Schwartz RB, Hedley-Whyte ET, et al. Diffusion-weighted imaging of fungal cerebral infection. AJNR Am J Neuroradiol 2005;26(5): 1115-1121.
36. Peltola V, Ruuskanen O, Svedström E. Magnetic resonance imaging of lung infections in children. Pediatr Radiol 2008;38(11):1225-1231.
37. Eibel R, Herzog P, Dietrich O, et al. Pulmonary abnormalities in immunocompromised patients: comparative detection with parallel acquisition MR imaging and thin-section helical CT. Radiology 2006;241(3):880-891.
38. Miller GG, Boivin G, Dummer JS, et al. Cytomegalovirus ventriculoencephalitis in a peripheral blood stem cell transplant recipient. Clin Infect Dis 2006;42(4):e26-e29. http://cid.oxfordjournals.org/content/42/4/e26.long. Published January 6, 2006.
39. Arribas JR, Storch GA, Clifford DB, Tselis AC. Cytomegalovirus encephalitis. Ann Intern Med 1996; 125(7):577-587.
40. Seo SK, Regan A, Cihlar T, et al. Cytomegalovirus ventriculoencephalitis in a bone marrow transplant recipient receiving antiviral maintenance: clinical and molecular evidence of drug resistance. Clin Infect Dis 2001;33(9):e105-e108. http://cid.oxfordjournals.org/content/33/9/e105.full. Published September 26, 2001.
41. Baskin HJ, Hedlund G. Neuroimaging of herpesvirus infections in children. Pediatr Radiol 2007;37 (10):949-963.
42. Pastore G, Mosso ML, Magnani C, Luzzatto L, Bianchi M, Terracini B. Physical impairment and social life goals among adult long-term survivors of childhood cancer: a population-based study from the childhood cancer registry of Piedmont, Italy. Tumori 2001;87(6):372-378.
43. Gurney JG, Kadan-Lottick NS, Packer RJ, et al. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 2003;97(3): 663-673.
44. Aziz NM, Oeffinger KC, Brooks S, Turoff AJ. Comprehensive long-term follow-up programs for pediatric cancer survivors. Cancer 2006;107(4):841-848.
45. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006;355(15): 1572-1582.
46. Chan MS, Roebuck DJ, Yuen MP, Li CK, Chan YL. MR imaging of the brain in patients cured of acute lymphoblastic leukemia: the value of gradient echo imaging. AJNR Am J Neuroradiol 2006;27(3): 548-552.
47. Löbel U, Sedlacik J, Sabin ND, et al. Three-dimensional susceptibility-weighted imaging and twodimensional T2*-weighted gradient-echo imaging of intratumoral hemorrhages in pediatric diffuse intrinsic pontine glioma. Neuroradiology 2010;52(12): 1167-1177.
48. Rutkowski S, Bode U, Deinlein F, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 2005;352 (10):978-986.
49. Geyer JR, Sposto R, Jennings M, et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. J Clin Oncol 2005;23 (30):7621-7631.
50. Lafay-Cousin L, Bouffet E, Hawkins C, Amid A, Huang A, Mabbott DJ. Impact of radiation avoidance on survival and neurocognitive outcome in infant medulloblastoma. Curr Oncol 2009;16(6): 21-28.
51. Nagel BJ, Palmer SL, Reddick WE, et al. Abnormal hippocampal development in children with medulloblastoma treated with risk-adapted irradiation. AJNR Am J Neuroradiol 2004;25(9):1575-1582.
52. Palmer SL, Reddick WE, Glass JO, Gajjar A, Goloubeva O, Mulhern RK. Decline in corpus callosum volume among pediatric patients with medulloblastoma: longitudinal MR imaging study. AJNR Am J Neuroradiol 2002;23(7):1088-1094.
53. Mabbott DJ, Noseworthy MD, Bouffet E, Rockel C, Laughlin S. Diffusion tensor imaging of white matter after cranial radiation in children for medulloblastoma: correlation with IQ. Neuro Oncol 2006;8 (3):244-252.
54. Reddick WE, Glass JO, Helton KJ, et al. Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate. AJNR Am J Neuroradiol 2005;26(5): 1263-1269.
55. Vázquez E, Castellote A, Piqueras J, et al. Second malignancies in pediatric patients: imaging findings and differential diagnosis. RadioGraphics 2003;23 (5):1155-1172.